These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8536510)

  • 1. Deficiency of water-soluble vitamins in Crohn's disease.
    Lavy A; Lachter J; Enat R; Kufman Y; Eidelman S
    Dig Dis Sci; 1995 Dec; 40(12):2549. PubMed ID: 8536510
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of deficiencies of essential trace elements and vitamins on the course of Crohn's disease.
    Waśko-Czopnik D; Paradowski L
    Adv Clin Exp Med; 2012; 21(1):5-11. PubMed ID: 23214293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple vitamin status in Crohn's disease. Correlation with disease activity.
    Kuroki F; Iida M; Tominaga M; Matsumoto T; Hirakawa K; Sugiyama S; Fujishima M
    Dig Dis Sci; 1993 Sep; 38(9):1614-8. PubMed ID: 8359072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption of water and electrolytes in Crohn's disease of the colon.
    Head LH; Heaton JW; Kivel RM
    Gastroenterology; 1969 Mar; 56(3):571-9. PubMed ID: 5766911
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitamins in the management of disease of the gut.
    Mallinson CN
    Practitioner; 1971 Jan; 206(231):91-102. PubMed ID: 5540200
    [No Abstract]   [Full Text] [Related]  

  • 6. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease.
    Breslin NP; Nash C; Hilsden RJ; Hershfield NB; Price LM; Meddings JB; Sutherland LR
    Am J Gastroenterol; 2001 Oct; 96(10):2934-8. PubMed ID: 11693329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-absorption of enteric-coated prednisolone. Normal absorption of non-enteric-coated prednisolone in a patient with Crohn's disease and massive intestinal resection.
    Olivesi A
    Therapie; 1985; 40(1):5-7. PubMed ID: 4002184
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is intestinal permeability really a genetic marker for Crohn's disease?
    Daum F
    J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):340-1. PubMed ID: 8492269
    [No Abstract]   [Full Text] [Related]  

  • 11. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers.
    Devani M; Cugno M; Vecchi M; Ferrero S; Di Berardino F; Avesani EC; de Franchis R; Colman RW
    Am J Gastroenterol; 2002 Aug; 97(8):2026-32. PubMed ID: 12190172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
    D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
    Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional disturbances in Crohn's disease.
    Harries AD; Heatley RV
    Postgrad Med J; 1983 Nov; 59(697):690-7. PubMed ID: 6359105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperplastic-like mucosal change in Crohn's disease: an unusual form of dysplasia?
    Kilgore SP; Sigel JE; Goldblum JR
    Mod Pathol; 2000 Jul; 13(7):797-801. PubMed ID: 10912940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
    Sandborn WJ; Tremaine WJ; Lawson GM
    Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malabsorption is a major contributor to underweight in Crohn's disease patients in remission.
    Vaisman N; Dotan I; Halack A; Niv E
    Nutrition; 2006 Sep; 22(9):855-9. PubMed ID: 16928471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological characterisation of Crohn's disease fistulae.
    Bataille F; Klebl F; Rümmele P; Schroeder J; Farkas S; Wild PJ; Fürst A; Hofstädter F; Schölmerich J; Herfarth H; Rogler G
    Gut; 2004 Sep; 53(9):1314-21. PubMed ID: 15306592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's disease complicated by adult-onset Still's disease.
    Kono M; Oshitani N; Sawa Y; Watanabe K; Kamata N; Oiso R; Inagawa M; Kawachiya T; Kawashima D; Sogawa M; Jinno Y; Watanabe K; Higuchi K; Matsumoto T; Arakawa T
    J Gastroenterol; 2003; 38(9):891-5. PubMed ID: 14564635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The half-and-half nail: a new sign of Crohn's disease? Report of four cases.
    Zágoni T; Sipos F; Tarján Z; Péter Z
    Dis Colon Rectum; 2006 Jul; 49(7):1071-3. PubMed ID: 16699971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of MRI in Crohn's disease.
    Sinha R; Murphy P; Hawker P; Sanders S; Rajesh A; Verma R
    Clin Radiol; 2009 Apr; 64(4):341-52. PubMed ID: 19264177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.